Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2024

May 8, 2024

30016_dirs_2024-05-08_1ca579cd-eb45-45a6-bc2a-0ddd64ab86c4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-05-06

Reporting Person: COLLINS Asha (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-06 Common Stock M 257 Acquired 779 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-06 Non-Qualified Stock Option (right-to-buy) $476.87 A 609 Acquired 2034-05-05 Common Stock (609) Direct
2024-05-06 Restricted Stock Unit $ A 262 Acquired Common Stock (262) Direct
2024-05-06 Restricted Stock Unit $ M 257 Disposed Common Stock (257) Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier.

F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event iss earlier.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event was earlier.